Table 1.
Ad, adenocarcinoma; Adsq, adenosquamous cell carcinoma; AWD, alive with disease; CBDCA, carboplatin; CDGP, nedaplatin; CPT-11, irinotecan; DC, docetaxel and carboplatin; DFI, disease free interval; DOD, death of disease; LN, lymph node; NED, no evidence of disease; SCC, squamous cell carcinoma; Small, small cell carcinoma; TC, taxol and carboplatin; 5FU, fluorouracil.